نتائج البحث 1111-1120 من 19548 لعملية البحث عن Two-phase
... (2) improves stroke outcomes at 3 months in patients who ... A Phase 3 Efficacy and Safety Study of Pitolisant in Patients with Prader-Willi Syndrome.
The investigators have chosen this population because 1) These mutations are the most common genetic causes of LQTS, and 2) Offspring will have high risk of ...
The purpose of this study is to understand how electrical stimulation of the brain can modulate and suppress interictal epileptiform activity as a step on the ...
... 2-year progression free survival (PFS) rate as compared to ACNS0122. ... A Phase 3 Efficacy and Safety Study of Pitolisant in Patients with Prader-Willi Syndrome.
This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...
... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...
The primary aim of this study is to establish the practicality of using two novel imaging modalities for the assessment of biomechanical properties of the aorta ...
Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA ... This is a Phase I/II study designed to evaluate ... two cycles of mosunetuzumab. An additional arm ...
This phase II trial studies how well inotuzumab ... Eligible patients presenting with apparent uterine confined grade 1, 2 ... 2 with 50% or more uterine ...
This is a Phase I/II study designed to evaluate ... توجّه للصفحة 22 · توجّه للصفحة 33 · التاليالصفحة ... توجّه للصفحة 22 · توجّه للصفحة 33 · التاليالصفحة ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.